ASX: AT4 | OTCQB: ATALF | 22 August 2026

AT4 Commences Wet Table Trials at Del Sol as Tungsten and Antimony Refining Pathways Advance

American Tungsten & Antimony Limited has commenced wet table gravity concentration trials at the Del Sol hydrometallurgical refinery in Amargosa Valley, Nevada, on both scheelite-bearing tungsten mineralisation and stibnite-bearing antimony mineralisation. The work programs are directed at two objectives: establishing the front-end concentration step required to expand Del Sol into ammonium paratungstate production, and optimising antimony concentration ahead of a full restart trial of the refinery’s existing alkaline leach and electrowinning circuit.

0t
Stibnite hauled to Del Sol
0
Engineering firms invited
0tpy
Permitted capacity sought
0US$m
DOE award negotiations

What Has Changed

Three days after being shortlisted by the US Department of Energy, AT4 has moved from stated strategy to physical work at the refinery. Material is on site, trials are running, and the engineering process is at the appointment stage.

  • Wet table trials have commenced on scheelite-bearing tungsten mineralisation from AT4’s Dutch Mountain Tungsten Project in Utah and from third-party sources located proximal to Del Sol.
  • Approximately three tonnes of stibnite-bearing mineralisation has been extracted from White Spar in Yavapai County, Arizona, and hauled to Del Sol, alongside samples and drill core from Antimony Canyon.
  • Engineering proposals have been received from shortlisted firms for the proposed APT expansion, with engagement of the preferred firm targeted within two weeks.
  • A full restart trial of the Del Sol antimony flake circuit is targeted to commence by the end of the September quarter 2026.
  • CEO Casper Adson and the Nexus Metals team will be in Washington D.C. and New York next week for a program of meetings with potential strategic stakeholders.

The Two Work Streams

What the Wet Table Program Is Designed to Establish

The program tests various feed sources across a range of crush and grind sizes. Select each outcome to expand.

Establish the WO3 grade of scheelite concentrate achievable by gravity alone, and the corresponding mass pull, across the range of feed sources being tested.

Quantify tungsten recovery to concentrate and identify where losses report, in particular to slimes and to middlings, to determine whether a regrind or scavenger stage is warranted.

Define the optimum grind size at which scheelite is liberated without over grinding. This is the single largest driver of both recovery and downstream operating cost.

Produce sufficient gravity concentrate to enable froth flotation to be assessed as a subsequent upgrade step.

Compare the behaviour of Dutch Mountain material against the third-party feed sources, to establish whether a single flowsheet can accommodate blended feed.

Produce sufficient representative scheelite concentrate for laboratory scale caustic leach and APT crystallisation testwork using the on-site Del Sol laboratory, which houses ICP-OES, fire assay and XRF capability.

Provide the empirical dataset that the appointed engineering firm will use to size and cost the front-end gravity circuit and the downstream APT circuit.

The trials have commenced and no samples have yet been submitted for assay. No testwork results are reported in the Company’s announcement. AT4 has stated it will report the outcomes of the program to the market once results have been received, compiled and reviewed.

Engineering and the Route to Non-Dilutive Funding

Requests for proposal were issued to five leading international engineering firms covering the proposed APT circuit at Del Sol, the expansion of antimony flake capacity and the addition of specialty antimony product circuits. Several proposals have been received. AT4 expects to complete its assessment and engage the preferred firm within the next two weeks.

The appointed firm will be scoped to deliver a design basis together with capital and operating cost estimates for a domestic United States APT refinery at Del Sol. The Company has stated that a defined, engineered and costed APT pathway is the technical foundation on which it intends to pursue non-dilutive United States debt and government funding programs.

That connects directly to the DOE shortlisting announced on 18 August 2026, under which AT4 was selected as one of nine projects nationally to commence negotiations on a potential award of up to US$18 million from a US$162 million federal initiative. Grant and loan programs of that type require an engineered basis of estimate. The engineering appointment is the step that produces it.

The Regulatory Driver

Executive Chair Tim Morrison framed the commercial case in the announcement, noting that the United States has no meaningful domestic production of either tungsten or antimony, and that Executive Order 14415 and the prohibition taking full effect on 1 January 2027 mean the defence industrial base has to find compliant domestic sources. Morrison stated that Del Sol is built, permitted, and has sources of United States tungsten and antimony today.

On the DOE shortlisting, Morrison said the selection confirms where United States Government investment is heading, being towards domestic mining, processing and manufacturing capacity across critical mineral supply chains, and that this is precisely what AT4 is building. He added that, on the basis of publicly available information, AT4 is not aware of any other United States company with refining infrastructure and domestic feed for both metals, and that the Company intends to be the first to bring them into production.

Chief Executive Officer Casper Adson said AT4 is entering an exciting phase, with tungsten and antimony samples from both internal and nearby third-party sources being processed at Del Sol to determine optimum conditions for the production of both tungsten APT and antimony flake, and that the engaged consultants, metallurgists and engineers are working alongside the AT4 team to identify the fastest and most efficient path forward for both circuits.

Restart Trial and Specialty Products

The concentration trials are the immediate precursor to a full restart trial of the Del Sol antimony flake circuit, targeted to commence by the end of the current quarter. The restart trial is intended to generate verified operating data across throughput, recovery, reagent consumption, power draw and product specification.

AT4 has stated those results are intended to feed four separate work streams: the capacity expansion engineering, the specialty product development program covering Regulus II antimony metal ingot, antimony trisulphide and sodium antimonate, commercial discussions with prospective offtake counterparties, and applications under United States federal programs supporting domestic critical minerals capability.

Strategic Engagement in Washington D.C. and New York

Chief Executive Officer Casper Adson, together with the Nexus Metals team, will be in Washington D.C. and New York next week for a program of meetings with potential strategic stakeholders. The stated aim is to introduce Del Sol as a constructed and permitted domestic refining asset and to accelerate the development pathway for both APT and antimony refining at the facility.

AT4 has been explicit about the limits of that engagement. Beyond the DOE shortlisting announced on 18 August 2026, the Company has no agreement, commitment, contract, grant, offtake or funding arrangement with any United States government agency or department, and no such arrangement is proposed as at the date of the announcement. There is no certainty that the meetings will result in any agreement, funding, offtake or transaction.

Next Steps

  • Complete wet table trial programs. Finalise the gravity concentration test programs on tungsten and antimony mineralisation.
  • Engage APT engineering firm. Review scoping study proposals and appoint the preferred firm within the next two weeks.
  • Laboratory scale APT testwork. Conduct caustic leach and APT crystallisation testwork on scheelite concentrate produced from the table trials, using the onsite Del Sol laboratory.
  • Del Sol full restart trial. Commence the restart trial of the antimony flake circuit by the end of the current quarter and capture baseline operating data.
  • NDEP applications. Progress the application to expand permitted feed capacity to 100,000 tons per year and the separate application to extend permit scope to tungsten refining.
  • Strategic engagement. Complete the Washington D.C. and New York meeting program and progress any resulting discussions.
  • Complete the Proposed Transaction. Satisfy the outstanding conditions precedent, including AT4 shareholder approval and exercise of the Del Sol option.

Completion of these work streams is subject to the availability of equipment, personnel, laboratory capacity, funding and regulatory approvals, and to completion of the Proposed Transaction. Timing is indicative only.

The Position

Within three days of the DOE shortlisting, AT4 has material on the ground at Del Sol, trials running on both metals, engineering proposals in hand and two permit applications in progress. The sequence is coherent: concentrate the feed, produce the empirical dataset, engineer and cost the circuits, then take that package to the federal funding programs.

This article is general information only. It is not financial product advice and does not take into account any person’s objectives, financial situation or needs. Investors should read the Company’s ASX announcements in full, including those dated 28 July 2026, 19 August 2026 and 21 August 2026, together with the cautionary and forward-looking statements contained in them, and obtain independent advice before making any investment decision.